4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-18-042389
SVP, Chief Commercial Officer sold 33,782 shares at $137.32 ($4,638,944)
- SVP, Chief Commercial Officer acquired 33,782 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cumbo Alexander · SVP, Chief Commercial Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-07-09 | Exercise or conversion : show line 1 in the form | +11,924 | $13.71 | $163,478 | 40,690 | D |
| 2018-07-09 | Sale : show line 2 in the form | −11,924 | $137.32 | $1,637,404 | 28,766 | D |
| 2018-07-09 | Exercise or conversion : show line 3 in the form | +9,944 | $13.71 | $136,332 | 38,710 | D |
| 2018-07-09 | Sale : show line 4 in the form | −9,944 | $137.32 | $1,365,510 | 28,766 | D |
| 2018-07-09 | Exercise or conversion : show line 5 in the form | +11,914 | $13.90 | $165,605 | 40,680 | D |
| 2018-07-09 | Sale : show line 6 in the form | −11,914 | $137.32 | $1,636,030 | 28,766 | D |
| Open-market sales · 33,782 sh · avg $137.32 · $4,638,944 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2018-07-09 | Exercise or conversion : show line 7 in the form Stock option (right to buy) | −11,924 | $13.71 | $163,478 | $13.71 | 2026-02-28 | 11,924 | 3,850 | D |
| 2018-07-09 | Exercise or conversion : show line 8 in the form Stock option (right to buy) | −9,944 | $13.71 | $136,332 | $13.71 | 2026-02-28 | 9,944 | 3,895 | D |
| 2018-07-09 | Exercise or conversion : show line 9 in the form Stock option (right to buy) | −11,914 | $13.90 | $165,605 | $13.90 | 2025-02-27 | 11,914 | 2,250 | D |
Loading xslF345X03/doc4.xml…